1. Home
  2. PHVS vs EDN Comparison

PHVS vs EDN Comparison

Compare PHVS & EDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHVS
  • EDN
  • Stock Information
  • Founded
  • PHVS 2015
  • EDN 1992
  • Country
  • PHVS Netherlands
  • EDN Argentina
  • Employees
  • PHVS N/A
  • EDN N/A
  • Industry
  • PHVS Biotechnology: Pharmaceutical Preparations
  • EDN Electric Utilities: Central
  • Sector
  • PHVS Health Care
  • EDN Utilities
  • Exchange
  • PHVS Nasdaq
  • EDN Nasdaq
  • Market Cap
  • PHVS 1.0B
  • EDN 1.0B
  • IPO Year
  • PHVS 2021
  • EDN 2007
  • Fundamental
  • Price
  • PHVS $21.25
  • EDN $31.36
  • Analyst Decision
  • PHVS Buy
  • EDN
  • Analyst Count
  • PHVS 6
  • EDN 0
  • Target Price
  • PHVS $35.67
  • EDN N/A
  • AVG Volume (30 Days)
  • PHVS 95.8K
  • EDN 205.6K
  • Earning Date
  • PHVS 11-15-2024
  • EDN 11-19-2024
  • Dividend Yield
  • PHVS N/A
  • EDN N/A
  • EPS Growth
  • PHVS N/A
  • EDN 11216.45
  • EPS
  • PHVS N/A
  • EDN 0.14
  • Revenue
  • PHVS N/A
  • EDN $972,768,196.00
  • Revenue This Year
  • PHVS N/A
  • EDN $144.81
  • Revenue Next Year
  • PHVS N/A
  • EDN $81.78
  • P/E Ratio
  • PHVS N/A
  • EDN $13.11
  • Revenue Growth
  • PHVS N/A
  • EDN N/A
  • 52 Week Low
  • PHVS $15.00
  • EDN $10.06
  • 52 Week High
  • PHVS $33.00
  • EDN $34.18
  • Technical
  • Relative Strength Index (RSI)
  • PHVS 46.38
  • EDN 75.46
  • Support Level
  • PHVS $22.86
  • EDN $30.83
  • Resistance Level
  • PHVS $25.40
  • EDN $32.97
  • Average True Range (ATR)
  • PHVS 1.56
  • EDN 1.96
  • MACD
  • PHVS -0.28
  • EDN 0.39
  • Stochastic Oscillator
  • PHVS 1.16
  • EDN 75.56

About PHVS Pharvaris N.V.

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases. The company's activities are considered to be one segment which comprises the discovery, development and commercialization of oral bradykinin-B2-receptor antagonists .

About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)

Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.

Share on Social Networks: